Introduction Metabolic syndrome (MetS) is defined by metabolic and cardio-vascular impairments and is frequently associated with anxiety and depressive disorders. Both MetS and anxiety-depressive syndromes feature similar systemic inflammatory alterations. Inflammation of the large bowel is also a key factor for the development of colorectal cancer (CRC). Objective To measure the prevalence of MetS and symptoms of anxiety and depression among patients undergoing colonoscopy. Methods Cross-sectional study. Patients undergoing colonoscopy aged 40 or more, with negative history for neoplasia or inflammatory bowel disease, were enrolled. Data collected: colonoscopy outcome, presence/absence of MetS (IDF and ATP III criteria), presence/absence of depressive and anxiety symptoms assessed with HADS. Results The sample was made up of 53 patients (female 24, 45.3%). Mean age was 60.66 ± 9.08. At least one adenoma was found to 23 patients (43.3%). Prevalence of MetS ranged from 34% to 36% (ATP III and IDF criteria, respectively). Prevalence of depressive and anxiety symptoms was 20% and 33%, respectively. Conclusion Prevalence of MetS, anxiety and depressive symptoms among patients undergoing colonoscopy was higher than in the general population.

Prevalence of metabolic syndrome and of symptoms of anxiety and depression in patients undergoing colonoscopy / Marchi, Mattia; Alboni, Silvia; Fabbrizi, Andrea; Feltri, L.; Galli, Giacomo; Guicciardi, Alessia; Mancini, Stefano; Mattei, Giorgio; Minarini, Alessandro; Perrone, Daniela; Rioli, Giulia; Roncucci, Luca; Sena, Paola; Ferrari, Silvia. - In: EUROPEAN PSYCHIATRY. - ISSN 0924-9338. - 41:(2017), pp. S318-S319. [10.1016/j.eurpsy.2017.02.236]

Prevalence of metabolic syndrome and of symptoms of anxiety and depression in patients undergoing colonoscopy

MARCHI, MATTIA;ALBONI, Silvia;FABBRIZI, ANDREA;Galli, Giacomo;Guicciardi, Alessia;MANCINI, Stefano;Mattei, Giorgio;MINARINI, ALESSANDRO;PERRONE, DANIELA;RIOLI, GIULIA;RONCUCCI, Luca;SENA, Paola;FERRARI, Silvia
2017

Abstract

Introduction Metabolic syndrome (MetS) is defined by metabolic and cardio-vascular impairments and is frequently associated with anxiety and depressive disorders. Both MetS and anxiety-depressive syndromes feature similar systemic inflammatory alterations. Inflammation of the large bowel is also a key factor for the development of colorectal cancer (CRC). Objective To measure the prevalence of MetS and symptoms of anxiety and depression among patients undergoing colonoscopy. Methods Cross-sectional study. Patients undergoing colonoscopy aged 40 or more, with negative history for neoplasia or inflammatory bowel disease, were enrolled. Data collected: colonoscopy outcome, presence/absence of MetS (IDF and ATP III criteria), presence/absence of depressive and anxiety symptoms assessed with HADS. Results The sample was made up of 53 patients (female 24, 45.3%). Mean age was 60.66 ± 9.08. At least one adenoma was found to 23 patients (43.3%). Prevalence of MetS ranged from 34% to 36% (ATP III and IDF criteria, respectively). Prevalence of depressive and anxiety symptoms was 20% and 33%, respectively. Conclusion Prevalence of MetS, anxiety and depressive symptoms among patients undergoing colonoscopy was higher than in the general population.
41
S318
S319
Marchi, Mattia; Alboni, Silvia; Fabbrizi, Andrea; Feltri, L.; Galli, Giacomo; Guicciardi, Alessia; Mancini, Stefano; Mattei, Giorgio; Minarini, Alessandro; Perrone, Daniela; Rioli, Giulia; Roncucci, Luca; Sena, Paola; Ferrari, Silvia
Prevalence of metabolic syndrome and of symptoms of anxiety and depression in patients undergoing colonoscopy / Marchi, Mattia; Alboni, Silvia; Fabbrizi, Andrea; Feltri, L.; Galli, Giacomo; Guicciardi, Alessia; Mancini, Stefano; Mattei, Giorgio; Minarini, Alessandro; Perrone, Daniela; Rioli, Giulia; Roncucci, Luca; Sena, Paola; Ferrari, Silvia. - In: EUROPEAN PSYCHIATRY. - ISSN 0924-9338. - 41:(2017), pp. S318-S319. [10.1016/j.eurpsy.2017.02.236]
File in questo prodotto:
File Dimensione Formato  
EPA2017_METS_1.pdf

accesso aperto

Tipologia: Abstract
Dimensione 53.03 kB
Formato Adobe PDF
53.03 kB Adobe PDF Visualizza/Apri
EPA2017_METS_2.pdf

accesso aperto

Tipologia: Abstract
Dimensione 52.19 kB
Formato Adobe PDF
52.19 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1142985
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact